SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-263976
Filing Date
2019-10-08
Accepted
2019-10-07 21:29:07
Documents
7
Period of Report
2019-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d795969d8k.htm 8-K 25301
2 EX-1.1 d795969dex11.htm EX-1.1 202877
3 EX-1.2 d795969dex12.htm EX-1.2 199804
4 EX-5.1 d795969dex51.htm EX-5.1 9655
5 EX-99.1 d795969dex991.htm EX-99.1 10297
6 GRAPHIC g795969g1005004137761.jpg GRAPHIC 6305
7 GRAPHIC g795969g1005004433897.jpg GRAPHIC 2647
  Complete submission text file 0001193125-19-263976.txt   461685
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 191141744
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences